Systemic Barriers in Receiving Electronically Prescribed Glaucoma Medications.
Journal
Journal of glaucoma
ISSN: 1536-481X
Titre abrégé: J Glaucoma
Pays: United States
ID NLM: 9300903
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
received:
21
04
2022
accepted:
19
07
2022
pubmed:
19
8
2022
medline:
1
10
2022
entrez:
18
8
2022
Statut:
ppublish
Résumé
Over a third of electronically prescribed glaucoma medications were not picked up within 1 month of patient request. Feedback-driven protocols may help minimize treatment interruptions attributed to electronic prescribing. Glaucoma treatment relies on long-term medication compliance and many socioeconomic factors impact the ability of patients to receive their medications. This study aims to quantify treatment interruptions attributable to electronically prescribed medications and propose interventions to minimize this barrier. This is a cross-sectional study of the electronic prescribing patterns at a tertiary care hospital serving a socioeconomically diverse patient population. Glaucoma medication refill requests received over a 6-week interval were reviewed and patient pharmacies were contacted 1 month after the request date to determine whether the medication was received by the patient. Patients who did not pick up the prescriptions were contacted and consented to participate in a survey to identify the barriers to acquiring the medications. Refill requests of 198 glaucoma medications met the inclusion criteria and the most common classes were prostaglandin analogs (44%) and alpha-2-agonists (21%). Medications were not obtained within 1 month in 71 (35.9%) cases. Prior authorization requirement was significantly associated with patients not obtaining their medication (odds ratio, 0.07; 95% confidence interval, 0.03-0.45). Patient reported challenges to successful receipt electronically prescribed medications included insurance coverage (32.2%) and pharmacy availability (22.6%). Approximately a third of electronically prescribed glaucoma medications were not received by patients within a month of refill request due to the need for prior authorization, insurance coverage, and pharmacy availability. A mechanism to alert providers and to address these barriers to medication access may minimize treatment interruption and disease progression.
Identifiants
pubmed: 35980860
doi: 10.1097/IJG.0000000000002100
pii: 00061198-202210000-00006
pmc: PMC9530008
mid: NIHMS1827219
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
812-815Subventions
Organisme : AHRQ HHS
ID : T32 HS000063
Pays : United States
Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure: The authors declare no conflict of interest.
Références
Robin A, Grover D. Compliance and adherence in glaucoma management. Indian J Ophthalmol. 2011;59:93.
Boland MV, Chang DS, Frazier T, et al. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study. JAMA Ophthalmol. 2014;132:838.
Ung C, Zhang E, Alfaro T, et al. Glaucoma severity and medication adherence in a county hospital population. Ophthalmology. 2013;120:1150–1157.
Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116:S30–S36.
Musicus AA, Vercammen KA, Fulay AP, et al. Implementation of a rooftop farm integrated with a teaching kitchen and preventive food pantry in a hospital setting. Am J Public Health. 2019;109:1119–1121.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573–577.
Pattin AJ, Devore N, Fowler J, et al. An examination of the prescription renewal process and implications for primary care physicians and community pharmacists. J Pharm Practice. 2020;33:187–191.
Lourenco LM, Bursua A, Groo VL. Automatic errors: a case series on the errors inherent in electronic prescribing. J Gen Intern Med. 2016;31:808–811.
Goldman RE, Dubé C, Lapane KL. Beyond the basics: refills by electronic prescribing. Int J Med Inform. 2010;79:507–514.
Singer A, Duarte Fernandez R. The effect of electronic medical record system use on communication between pharmacists and prescribers. BMC Fam Pract. 2015;16:155.
Tai-Seale M, Olson CW, Li J, et al. Electronic health record logs indicate that physicians split time evenly between seeing patients and desktop medicine. Health Aff (Millwood). 2017;36:655–662.
Grossman JM, Cross DA, Boukus ER, et al. Transmitting and processing electronic prescriptions: experiences of physician practices and pharmacies. J Am Med Inform Assoc. 2012;19:353–359.
Connor AJ, Hutton P, Severn P, et al. Electronic prescribing and prescription design in ophthalmic practice. Eur J Ophthalmol. 2011;21:644–648.
Kaushal R, Kern LM, Barrón Y, et al. Electronic prescribing improves medication safety in community-based office practices. J Gen Intern Med. 2010;25:530–536.
Kannry J. Effect of e-prescribing systems on patient safety. Mt Sinai J Med. 2011;78:827–833.
Lämsä E, Timonen J, Ahonen R. Pharmacy customers’ experiences with electronic prescriptions: cross-sectional survey on nationwide implementation in Finland. J Med Internet Res. 2018;20:e68.
Gazmararian JA, Kripalani S, Miller MJ, et al. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006;21:1215–1221.